ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
21.04
+0.15 (0.72%)
Jun 3, 2026, 12:17 PM EDT - Market open
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, ACADIA Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $31.65. The average 1-year stock price forecast is 50.43% higher than the current stock price, while the lowest is $17 (-19.20%) and the highest is $45 (+113.88%).
Price Target: $31.65 (+50.43%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 11 | 12 | 12 | 12 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 6 | 6 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 20 | 20 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold Maintains $23 | Hold | Maintains | $23 | +9.32% | May 22, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $34 | Buy | Maintains | $34 | +61.60% | May 11, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 8, 2026 |
| Citi | Citi | Buy Maintains $33 → $32 | Buy | Maintains | $33 → $32 | +52.09% | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
Financial Forecast
Revenue This Year
1.24B
from 1.07B
Increased by 15.83%
Revenue Next Year
1.39B
from 1.24B
Increased by 11.88%
EPS This Year
0.39
from 2.30
Decreased by -83.15%
EPS Next Year
0.72
from 0.39
Increased by 85.69%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | ||
| Avg | 1.2B | ||
| Low | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.9% | ||
| Avg | 15.8% | ||
| Low | 14.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.61 | ||
| Avg | 0.39 | ||
| Low | 0.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -73.5% | ||
| Avg | -83.2% | ||
| Low | -90.0% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.